AJMC - The American Journal of Managed Care

This issue of Amplifying Managed Care News dives into vital health care conversations you won’t want to miss—from the ongoing barriers in childhood #cancercare and innovative strategies to improve oncology access, to new insights on #ACA coverage’s impact on young adult health, and how #AI is shaping the future of health care with trust and innovation. Stay informed, stay ahead!

📊 New Survey Highlights a Major Challenge for Medicare Beneficiaries According to a recent analysis by eHealth, Inc., 75% of Medicare beneficiaries say that choosing a plan is confusing. Many are unaware of important changes coming in 2026, and misconceptions persist—such as believing Medicare covers certain weight loss drugs or not realizing that vaccines are covered at no cost. With Medicare Advantage (MA) enrollment projected to decline this year due to insurers cutting unprofitable plans, the stakes of making the “wrong” choice are higher than ever. 👉 What can be done? 1. Educate beneficiaries about plan differences (MA, Supplement, Part D) 2. Simplify comparison tools 3. Leverage AI or digital assistance to guide plan selection 4. Proactively communicate upcoming plan changes If you work in health policy, insurance, benefits administration, or health care delivery, let’s collaborate on tools, communication strategies, and innovations that help seniors make more informed choices. https://hubs.li/Q03LVY9D0 #Medicare #HealthPolicy #HealthTech #SeniorCare #Insurance #DigitalHealth #AI

Clinician-led partnerships are designed to make post-acute care stronger. At OneHome, we help patients get the right care, in the right place, at the right time. Read the article: https://hubs.li/Q03LHGTk0 #ValueBasedCare #HealthcareInnovation

President Trump’s #MostFavoredNation order could redefine drug pricing, with far-reaching implications for payers, PBMs, and patient access. For managed care leaders, the stakes have never been higher. In part 2 of our 3-part series, experts will examine the legal challenges already emerging, the market shifts on the horizon, and the consequences for patient affordability. Join us live on October 8 at 7:00 PM EDT for this critical discussion. Reserve your spot: https://hubs.li/Q03LPstp0

🇺🇸 The US Government Shutdown and What It Means for Health Care As of October 1, 2025, the federal government has entered a shutdown — and health care is already feeling the impact. From telehealth to ambulance services to insurance premiums, patients and providers face uncertainty. 📌 Key impacts: Telehealth & home care: Expanded pandemic-era rules could expire, limiting virtual care access for seniors, rural patients, and those with chronic conditions. Ambulance services: Loss of supplemental payments could reduce service capacity, especially in rural areas, and delay emergency response times. Insurance costs: Affordable Care Act (ACA) subsidy lapses could sharply increase premiums, potentially doubling costs for some and affecting millions of Americans. The shutdown underscores deep partisan divisions over health care funding, with Democrats pushing to extend ACA subsidies and Republicans calling for separate debate on health policy. https://hubs.li/Q03LLGtL0 #HealthCare #GovernmentShutdown #HealthPolicy

At the #ERS2025 Congress, experts sounded the alarm on growing threats to scientific integrity: predatory publishing, political interference, and industry-driven misinformation. These challenges not only undermine research quality but also threaten the role of science in shaping health policy. Speakers highlighted how: 1. Predatory journals exploit open-access publishing models, prioritizing profit over quality. 2. Political interference can override peer review and cut funding for critical research, from climate change to health equity. 3. Industry influence — long practiced by tobacco companies — now extends to new sectors, spreading misinformation through subtle tactics. Early-career researchers face particular risks, from publication pressure to limited funding, making awareness and training essential. Medical societies like ERS have a key role to play — by strengthening codes of conduct, resisting undue influence, and equipping researchers to defend evidence-based science. A call to action: safeguard scientific independence through education, transparent funding models, and bold public engagement. #HealthPolicy #ScientificIntegrity #MedicalResearch #ERS2025 #PredatoryPublishing #ScienceAdvocacy https://hubs.li/Q03LBmJG0

At #ERS2025, Michaela Nuttal, MS, explores the complex culture of #smoking among nurses, highlighting challenges and motivations for quitting within health care settings. Watch now! https://hubs.li/Q03LBnHH0

Join us for Driving the Future of Cancer Care in New York! https://lnkd.in/ebaN-aHv Date: October 9, 2025 Time: 5:00-9:00 PM EDT Location: The Westin New York at Times Square, New York, NY Join us in New York, New York, for an evening of insight and collaboration at this FREE event, where industry leaders will gather to explore cutting-edge strategies to enhance patient care and drive innovation in oncology. Discussion Highlights: · The Power of Team-Based Oncology · Delivering on the Promise of Precision Oncology · Collaborating With Your Pharmacist to Optimize Value in Oncology · Access First, Outcomes Next: Addressing SDOH in Clinical Trial Participation Be part of the conversation and help shape the future of cancer care! Register here: https://lnkd.in/ebaN-aHv  #IVBM #OncologyCare #New York

At #ERS2025, Justin M. Oldham, MD, PhD, MS, pulmonary fibrosis specialist, director of interstitial lung disease, and clinical associate professor of internal medicine at the University of Michigan Medical School, shares findings from the phase 3 FIBRONEER-IPF (NCT05321069) and FIBRONEER-ILD (NCT05321082) trials over the prolonged exposure time of 76 weeks on the safety and tolerability of #nerandomilast. Watch here: https://hubs.li/Q03LB7wR0